BCDA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
BioCardia Inc (BCDA) is not a good buy for a beginner investor with a long-term strategy at this moment. The stock shows no strong positive catalysts, weak financial performance, and no significant trading signals to suggest immediate upside potential.
The technical indicators are mixed to bearish. The MACD is slightly positive and expanding, but RSI is neutral at 51.14, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 1.183, with resistance at 1.259 and support at 1.106. There is no clear upward momentum.
NULL identified. There is no recent news, no significant hedge fund or insider activity, and no congress trading data.
Weak financial performance in Q4 2025, with revenue at 0, net income dropping by -13.59% YoY, EPS declining by -62.00% YoY, and gross margin falling to 0%. No recent trading signals from AI Stock Picker or SwingMax.
The company's Q4 2025 financials are weak. Revenue remained at 0, net income dropped to -1,984,000 (-13.59% YoY), EPS fell to -0.19 (-62.00% YoY), and gross margin dropped to 0 (-100.00% YoY).
No analyst rating or price target data available.
